Celldex Therapeutics, Inc. (CLDX)
39.47
+0.23
(+0.59%)
USD |
NASDAQ |
Sep 02, 16:00
39.47
0.00 (0.00%)
After-Hours: 20:00
Celldex Therapeutics Price : 39.47 for Sept. 2, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 01, 2026 | 39.13 | 39.90 | 38.94 | 39.24 | 542484.0 |
| Aug 31, 2026 | 38.86 | 39.84 | 38.74 | 39.63 | 696907.0 |
| Aug 28, 2026 | 40.33 | 40.57 | 39.04 | 39.12 | 424938.0 |
| Aug 27, 2026 | 40.44 | 41.00 | 40.02 | 40.46 | 450009.0 |
| Aug 26, 2026 | 41.18 | 42.12 | 40.06 | 40.57 | 540669.0 |
| Aug 25, 2026 | 41.02 | 41.92 | 40.63 | 41.22 | 550919.0 |
| Aug 24, 2026 | 40.16 | 40.98 | 39.53 | 40.57 | 416889.0 |
| Aug 21, 2026 | 40.38 | 41.24 | 40.12 | 40.38 | 837685.0 |
| Aug 20, 2026 | 41.40 | 42.00 | 39.45 | 39.94 | 1.003M |
| Aug 19, 2026 | 42.10 | 43.20 | 41.32 | 41.70 | 1.392M |
| Aug 18, 2026 | 41.29 | 42.36 | 41.03 | 41.79 | 998962.0 |
| Aug 17, 2026 | 41.54 | 42.80 | 41.07 | 41.92 | 629804.0 |
| Aug 14, 2026 | 42.23 | 42.34 | 40.88 | 41.95 | 849365.0 |
| Aug 13, 2026 | 45.13 | 45.13 | 42.56 | 42.61 | 670930.0 |
| Aug 12, 2026 | 44.40 | 45.14 | 43.80 | 44.87 | 1.595M |
| Aug 11, 2026 | 42.81 | 44.60 | 42.46 | 44.33 | 767368.0 |
| Aug 10, 2026 | 41.71 | 43.21 | 41.41 | 42.97 | 727631.0 |
| Aug 07, 2026 | 41.87 | 42.92 | 41.29 | 41.71 | 808913.0 |
| Aug 06, 2026 | 41.12 | 41.74 | 40.84 | 41.56 | 799089.0 |
| Aug 05, 2026 | 39.36 | 41.15 | 38.86 | 41.06 | 788876.0 |
| Aug 04, 2026 | 37.69 | 39.34 | 37.54 | 39.05 | 1.027M |
| Aug 03, 2026 | 38.09 | 38.59 | 37.05 | 37.69 | 1.635M |
| Jul 31, 2026 | 38.50 | 38.65 | 37.15 | 38.06 | 875735.0 |
| Jul 30, 2026 | 37.26 | 38.59 | 37.23 | 38.48 | 743234.0 |
| Jul 29, 2026 | 35.58 | 37.76 | 35.58 | 37.51 | 1.573M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Gilead Sciences, Inc. | 149.61 |
| Ionis Pharmaceuticals, Inc. | 61.31 |
| ACADIA Pharmaceuticals, Inc. | 28.92 |
| Alnylam Pharmaceuticals, Inc. | 267.29 |
| Anika Therapeutics, Inc. | 21.57 |
Price Related Metrics
| PS Ratio | 17319.02 |
| PEG Ratio | -0.2017 |
| Price to Book Value | 4.336 |
| Earnings Yield | -11.04% |
| Market Cap | 3.098B |
| PEGY Ratio | -0.2017 |